Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.
Sayitoglu M, Haznedaroğlu IC, Hatirnaz O, Erbilgin Y, Aksu S, Koca E, Adiguzel C, Bayik M, Akalin I, Gülbas Z, Akay M, Unal A, Kaynar L, Ovali E, Yilmaz M, Yenerel M, Dagdas S, Ozet G, Ar C, Aydin Y, Soysal T, Durgun B, Ozcebe O, Tukun A, Ilhan O, Ozbek U. Sayitoglu M, et al. Among authors: bayik m. J Int Med Res. 2009 Jul-Aug;37(4):1018-28. doi: 10.1177/147323000903700406. J Int Med Res. 2009. PMID: 19761684 Free article. Clinical Trial.
Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
Kaygusuz-Atagunduz I, Toptas T, Yumuk F, Firatli-Tuglular T, Bayik M. Kaygusuz-Atagunduz I, et al. Among authors: bayik m. J Cancer Res Ther. 2014 Oct-Dec;10(4):1107-8. doi: 10.4103/0973-1482.146095. J Cancer Res Ther. 2014. PMID: 25579564 Free article.
Hairy cell leukemia in father and son.
Cetiner M, Adigüzel C, Argon D, Ratip S, Eksioglu-Demiralp E, Tecimer T, Bayik M. Cetiner M, et al. Among authors: bayik m. Med Oncol. 2003;20(4):375-8. doi: 10.1385/MO:20:4:375. Med Oncol. 2003. PMID: 14716034 Review.
Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: results of a randomized multicenter phase III trial.
Beksac M, Ali R, Ozcelik T, Ozcan M, Ozcebe O, Bayik M, Paydas S, Buyukasik Y, Ilhan O, Ozkalemkas F, Gurman G, Uysal A, Akan H, Soydan EA, Tunali A. Beksac M, et al. Among authors: bayik m. Leuk Res. 2011 Mar;35(3):340-5. doi: 10.1016/j.leukres.2010.07.005. Epub 2010 Jul 29. Leuk Res. 2011. PMID: 20673585 Clinical Trial.
44 results